{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:19:07Z","timestamp":1786997947564,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["218267\/Z\/19\/Z."],"award-info":[{"award-number":["218267\/Z\/19\/Z."]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["218267\/Z\/19\/"],"award-info":[{"award-number":["218267\/Z\/19\/"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.vaccine.2025.126913","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T22:38:17Z","timestamp":1740609497000},"page":"126913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Development of invasive non-typhoidal Salmonella conjugate vaccines and their evaluation in a trivalent formulation with typhoid conjugate vaccine"],"prefix":"10.1016","volume":"52","author":[{"given":"So Jung","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Seung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Hwa","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Sung","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Eun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Ganapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchir Kumar","family":"Pansuriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Ah","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon Kyung","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seul Bee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Hee","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soh-Won","family":"Kweon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Ji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Han","family":"Seon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manki","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Supplement_1","key":"10.1016\/j.vaccine.2025.126913_bb0005","first-page":"S32","article-title":"Nontyphoidal Salmonella Invasive Disease: Challenges and Solutions. Open Forum","volume":"10","author":"Crump","year":"2023","journal-title":"Infect Dis Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126913_bb0010","first-page":"523","article-title":"Incidence of non-typhoidal Salmonella invasive disease: A systematic review and meta-analysis","volume":"83","author":"Marchello","year":"2021","journal-title":"J Inf Secur"},{"issue":"9835","key":"10.1016\/j.vaccine.2025.126913_bb0015","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/S0140-6736(11)61752-2","article-title":"Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa","volume":"379","author":"Feasey","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126913_bb0020","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3201\/eid2106.140999","article-title":"Global burden of invasive nontyphoidal Salmonella disease, 2010(1)","volume":"21","author":"Ao","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126913_bb0025","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1128\/CMR.00002-15","article-title":"Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections","volume":"28","author":"Crump","year":"2015","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126913_bb0030","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S1473-3099(19)30418-9","article-title":"The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017","volume":"19","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126913_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005376","article-title":"The burden of typhoid fever in low- and middle-income countries: a meta-regression approach","volume":"11","author":"Antillon","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126913_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008440","article-title":"High relatedness of invasive multi-drug resistant non-typhoidal Salmonella genotypes among patients and asymptomatic carriers in endemic informal settlements in Kenya","volume":"14","author":"Kariuki","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126913_bb0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/nyas.12380","article-title":"Antibacterial resistance in sub-Saharan Africa: an underestimated emergency","volume":"1323","author":"Kariuki","year":"2014","journal-title":"Ann N Y Acad Sci"},{"issue":"Supplement_1","key":"10.1016\/j.vaccine.2025.126913_bb0050","first-page":"S58","article-title":"Salmonella Combination Vaccines: Moving Beyond Typhoid. Open Forum","volume":"10","author":"MacLennan","year":"2023","journal-title":"Infect Dis Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126913_bb0055","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ab.2012.10.038","article-title":"A scalable method for O-antigen purification applied to various Salmonella serovars","volume":"434","author":"Micoli","year":"2013","journal-title":"Anal Biochem"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126913_bb0060","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1128\/IAI.05484-11","article-title":"Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis","volume":"79","author":"Simon","year":"2011","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126913_bb0065","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1128\/iai.60.11.4679-4686.1992","article-title":"Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine","volume":"60","author":"Watson","year":"1992","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126913_bb0070","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/jvi.32.2.583-592.1979","article-title":"Salmonella bacteriophage glycanases: endorhamnosidases of Salmonella typhimurium bacteriophages","volume":"32","author":"Svenson","year":"1979","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126913_bb0075","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1128\/IAI.68.3.1529-1534.2000","article-title":"Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam","volume":"68","author":"Konadu","year":"2000","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126913_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23071749","article-title":"Immunogenicity and Induction of Functional Antibodies in Rabbits Immunized with a Trivalent Typhoid-Invasive Nontyphoidal Salmonella Glycoconjugate Formulation","volume":"23","author":"Baliban","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126913_bb0085","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1080\/14760584.2023.2270596","article-title":"The iNTS-GMMA vaccine: a promising step in non-typhoidal Salmonella vaccine development","volume":"22","author":"Skidmore","year":"2023","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126913_bb0090","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3390\/vaccines11111671","article-title":"Induction of Broad Immunity against Invasive Salmonella Disease by a Quadrivalent Combination Salmonella MAPS Vaccine Targeting Salmonella Enterica Serovars Typhimurium, Enteritidis, Typhi, and Paratyphi A","volume":"11","author":"Boerth","year":"2023","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126913_bb0095","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-005659","article-title":"The genomic epidemiology of multi-drug resistant invasive non-typhoidal Salmonella in selected sub-Saharan African countries","volume":"6","author":"Park","year":"2021","journal-title":"BMJ Glob Health"},{"issue":"21","key":"10.1016\/j.vaccine.2025.126913_bb0100","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.vaccine.2014.02.090","article-title":"Purification of O-specific polysaccharide from lipopolysaccharide produced by Salmonella enterica serovar Paratyphi A","volume":"32","author":"Kothari","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126913_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005493","article-title":"Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa","volume":"11","author":"Baliban","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2025.126913_bb0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biologicals.2018.09.001","article-title":"Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG","volume":"56","author":"Rijpkema","year":"2018","journal-title":"Biologicals"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126913_bb0115","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1517\/17460441.2011.609554","article-title":"The design of semi-synthetic and synthetic glycoconjugate vaccines","volume":"6","author":"Costantino","year":"2011","journal-title":"Expert Opin Drug Discov"},{"issue":"18","key":"10.1016\/j.vaccine.2025.126913_bb0120","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1002\/chem.201603599","article-title":"An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity","volume":"23","author":"Khatun","year":"2017","journal-title":"Chemistry"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126913_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23061451","article-title":"Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends","volume":"23","author":"Micoli","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.vaccine.2025.126913_bb0130","first-page":"153","article-title":"Preparation of polysaccharide-conjugate vaccines","volume":"87","author":"Peeters","year":"2003","journal-title":"Methods Mol Med"},{"issue":"42","key":"10.1016\/j.vaccine.2025.126913_bb0135","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1016\/j.vaccine.2013.07.078","article-title":"Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines","volume":"31","author":"Tontini","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126913_bb0140","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1473-3099(21)00455-2","article-title":"Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial","volume":"22","author":"Kumar Rai","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126913_bb0145","doi-asserted-by":"crossref","first-page":"20488","DOI":"10.1038\/srep20488","article-title":"Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites","volume":"6","author":"M\u00f6ginger","year":"2016","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126913_bb0150","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1039\/C4SC01361A","article-title":"Deciphering the structure\u2013immunogenicity relationship of anti-Candida glycoconjugate vaccines","volume":"5","author":"Adamo","year":"2014","journal-title":"Chem Sci"},{"issue":"46","key":"10.1016\/j.vaccine.2025.126913_bb0155","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1016\/j.vaccine.2014.08.056","article-title":"Impact of conjugation chemistry on the immunogenicity of S. typhimurium conjugate vaccines","volume":"32","author":"Stefanetti","year":"2014","journal-title":"Vaccine"},{"issue":"44","key":"10.1016\/j.vaccine.2025.126913_bb0160","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.1016\/j.vaccine.2011.08.019","article-title":"Physico-chemical properties of Salmonella typhi Vi polysaccharide-diphtheria toxoid conjugate vaccines affect immunogenicity","volume":"29","author":"An","year":"2011","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126913_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-072938","article-title":"Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort","volume":"13","author":"Hanumunthadu","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2025.126913_bb0170","series-title":". Carbohydrate-Based Vaccines: From Concept to Clinic","article-title":"Formulation Development of Glycoconjugate Vaccines for Low- and Middle-Income Countries","volume":"1290","author":"Khandke","year":"2018"},{"key":"10.1016\/j.vaccine.2025.126913_bb0175","article-title":"Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases","volume":"11","author":"Stefanetti","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"34","key":"10.1016\/j.vaccine.2025.126913_bb0180","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: A review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126913_bb0185","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fimmu.2017.00168","article-title":"Immunogenicity of a Bivalent Adjuvanted Glycoconjugate Vaccine against Salmonella Typhimurium and Salmonella Enteritidis","volume":"8","author":"Fiorino","year":"2017","journal-title":"Front Immunol"},{"issue":"43","key":"10.1016\/j.vaccine.2025.126913_bb0190","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1016\/j.vaccine.2014.08.010","article-title":"Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection","volume":"32","author":"Townsend","year":"2014","journal-title":"Vaccine"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2025.126913_bb0195","doi-asserted-by":"crossref","first-page":"B10","DOI":"10.1016\/j.vaccine.2011.12.060","article-title":"History of meningococcal vaccines and their serological correlates of protection","volume":"30","author":"Vipond","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126913_bb0200","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/INF.0b013e3181c67f04","article-title":"Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United Kingdom","volume":"29","author":"Goldblatt","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126913_bb0205","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00087-21","article-title":"Immunogenicity and Efficacy of Live-Attenuated Salmonella Typhimurium Vaccine Candidate CVD 1926 in a Rhesus Macaque Model of Gastroenteritis","volume":"89","author":"Higginson","year":"2021","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2025.126913_bb0210","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3389\/fimmu.2017.01916","article-title":"Salmonella Typhi Bactericidal Antibodies Reduce Disease Severity but Do Not Protect against Typhoid Fever in a Controlled Human Infection Model","volume":"8","author":"Juel","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126913_bb0215","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41541-023-00715-w","article-title":"Emerging vaccine strategies against the incessant pneumococcal disease","volume":"8","author":"Duke","year":"2023","journal-title":"npj Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126913_bb0220","article-title":"Immunogenicity of Current and Next-Generation Pneumococcal Conjugate Vaccines in Children: Current Challenges and Upcoming Opportunities. Open Forum","volume":"11","author":"Feemster","year":"2024","journal-title":"Infect Dis Ther"},{"issue":"19s1","key":"10.1016\/j.vaccine.2025.126913_bb0225","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.vaccine.2024.04.045","article-title":"Vaccine value profile for invasive non-typhoidal Salmonella disease","volume":"42","author":"Martin","year":"2024","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25002105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25002105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:32:50Z","timestamp":1778679170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25002105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":45,"alternative-id":["S0264410X25002105"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126913","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of invasive non-typhoidal Salmonella conjugate vaccines and their evaluation in a trivalent formulation with typhoid conjugate vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126913"}}